Stembios Technologies, Inc.
Records under this name other than the patents Stembios Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 7 of 7 · Back to Stembios Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,072,719 | Somatic stem cells Lapsed on the fee record Ended Jul 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | From the USPTO record |
| US 10,143,710 | Somatic stem cells Lapsed on the fee record Ended Dec 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2022 | From the USPTO record |
| US 9,810,684 | Method for increasing number of stem cells in human or animal bodies Lapsed on the fee record Ended Nov 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2021 | From the USPTO record |
| US 9,777,259 | Somatic stem cells Lapsed on the fee record Ended Oct 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2021 | From the USPTO record |
| US 9,770,473 | Treatment of immunosuppression-related disorders Lapsed on the fee record Ended Sep 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2021 | From the USPTO record |
| US 8,394,630 | Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs) Lapsed on the fee record Ended Mar 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 12, 2021 | From the USPTO record |
| US 9,415,073 | Somatic stem cells Lapsed on the fee record Ended Aug 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 16, 2020 | From the USPTO record |